Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Aide Advises FDA Dialogue, Not Legislation, To Obtain User Fee Relief

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers seeking to revise CDRH performance goals and user fee collection targets are unlikely to find a suitable vehicle in MDUFMA "trigger-fix" legislation this fall

You may also be interested in...



User Fee Renegotiations During Trigger Fix Could Endanger Program – Schultz

CDRH is crediting the device user fee program with bringing greater visibility and leverage to the device sector and is urging cooperation to ensure the program does not lapse at the end of fiscal 2005

User Fee Renegotiations During Trigger Fix Could Endanger Program – Schultz

CDRH is crediting the device user fee program with bringing greater visibility and leverage to the device sector and is urging cooperation to ensure the program does not lapse at the end of fiscal 2005

Pediatric Device R&D, Funding Collaborations Urged By Senate HELP Staffer

FDA needs to refine its premarket path for pediatric devices, Vipul Mankad, MD, Robert Wood Johnson health policy fellow on the Senate HELP Committee, told participants at a June 24 Institute of Medicine panel meeting

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel